American Well Corp (NYSE:AMWL)
$ 11.39 -0.53 (-4.44%) Market Cap: 193.75 Mil Enterprise Value: 13.88 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 52/100

Q4 2025 American Well Corp Earnings Call Transcript

Feb 12, 2026 / 10:00PM GMT
Release Date Price: $4.33 (+0.23%)

Key Points

Positve
  • American Well Corp (AMWL) has sharpened its focus and executed a major transformation, aiming for cash flow break-even from operations by Q4 2026.
  • The company has successfully renewed over 15 payer contracts, securing a significant portion of its recurring revenue base.
  • AMWL's tech platform enables a unified approach to healthcare, allowing for efficient patient engagement and vendor management.
  • The company has reduced its cost base significantly, leading to improved financial performance and a clearer path to profitability.
  • AMWL has a strong cash position with $182 million in cash and marketable securities and no debt, providing financial stability.
Negative
  • Total revenue for Q4 2025 was $55.3 million, representing a 22.1% year-over-year decline, primarily due to contract step-downs and business reprioritization.
  • Subscription revenue decreased by 22% year-over-year, impacted by the DHA contract step-down and earlier churn.
  • The company experienced a decline in total platform visits, down 28.4% year-over-year, reflecting portfolio changes.
  • Gross margin declined by 280 basis points year-over-year, indicating near-term margin pressure despite a shift towards higher-margin offerings.
  • AMWL faces challenges with clinician shortages and increasing healthcare costs, particularly in behavioral health and GLP-1 usage.
Operator

Hello, everyone, and welcome to AMW's conference call to discuss their fourth fiscal quarter in full year 2025.

Joining us on the call today are AW's Chairman and CEO Doctor Ito Schoenberg and Mark Hirshhorn, Mwell's CFO and Chief Operating Officer.

Earlier today, a press release was distributed detailing their announcement. Their earnings report is posted on the amwell website at investors. Amwell.com and it's also available through normal news sources. This conference call is being webcast live on the IR page of the website where replay will be archived.

Before they begin prepared remarks, I'd like to take this opportunity to remind you that during the call we will make forward-looking statements regarding projected operating results and anticipated market opportunities.

This forward-looking information is subject to risk and uncertainty as described in the filings with the SEC.

Actual results or events may differ materially.

Except as required by law, we undertake no obligation to update or revise these four looking statements on this call, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot